Ensysce BiosciencesENSC
13F holders, Q4 2024 (December 31)8holders
$8.14avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Ensysce Biosciences Inc. (ENSC) in their 13F filings. The largest holders were Perceptive Advisors LLC ($705K), Adage Capital Partners Gp, L.L.C. ($407K) and FNY Investment Advisers, LLC ($24K).
- Company
- Ensysce Biosciences Inc.
- CUSIP
- 293602504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $1.1M |
| Exits | 0 | $0 |
Ownership 8 holders
| Perceptive Advisors LLC | 0.02% | New | 86,666 | $705K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 50,000 | $407K |
| FNY Investment Advisers, LLC | 0.01% | New | 3,000 | $24K |
| UBS Group AG | 0.00% | New | 595 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 438 | $4K |
| BlackRock, Inc. | 0.00% | New | 64 | $521 |
| Morgan Stanley | 0.00% | New | 52 | $423 |
| Bank of America Corp. | 0.00% | New | 8 | $65 |
"% of holder's portfolio" is ENSC's weight in each manager's 13F, not the share of Ensysce Biosciences Inc. the manager owns.